Filing search / Ownership / Delcath Systems, Inc. / Page 31

CT ORDER

ace46uiwgqt

24 Mar 11

Confidential treatment order

12:00am

8-K

ilpqg27zb1f8p3u gw

8 Mar 11

Regulation FD Disclosure

12:00am

8-K

8sfv62

25 Feb 11

Delcath Systems, Inc. Conference Call

12:00am

8-K

lls6ki sra7m

23 Feb 11

Delcath Systems Receives Refusal to File Letter from Fda

12:00am

8-K

wxcd43plq5knyei

8 Feb 11

Regulation FD Disclosure

12:00am

8-K

m6xxcy1bj652klpbe

25 Jan 11

Departure of Directors or Certain Officers

12:00am

8-K/A

4bkb fwov35euobbzccd

12 Jan 11

Financial Statements and Exhibits

12:00am

8-K

9sn8lg85

11 Jan 11

Regulation FD Disclosure

12:00am

8-K

b8hz vgjbuy1h9cg

27 Dec 10

Delcath Completes New Drug Application Submission

12:00am

8-K

a163v jdc9g2h

20 Dec 10

Departure of Directors or Certain Officers

12:00am

8-K

ftc6q fizr

6 Dec 10

Other Events

12:00am

8-K

tqe4jbgew1g8 xblo9

5 Nov 10

3rd QUARTER 2010 FINANCIAL RESULTS CONFERENCE CALL

12:00am

CT ORDER

sjxc0 411n6j

26 Oct 10

Confidential treatment order

12:00am

8-K

m5kyg 2gzux

19 Oct 10

Delcath Signs Agreement with Synerx and Mylan’s Bioniche Teoranta for Melphalan Supply

12:00am

8-K

v11ffw0jb5v5u yj

30 Sep 10

Entry into a Material Definitive Agreement

12:00am

8-K

oycf2l8

17 Aug 10

Delcath Systems Announces the Sale of 5,185,000 Million Shares

12:00am